Notice 23 Apr 2025 compliance, healthcare, regulation, pharmaceuticals, dea, controlled substances, drug enforcement, business consequences

⚖️DEA Revocation Decision Impacting De Novo Services, LLC

The Drug Enforcement Administration (DEA) has issued an order revoking the registration of De Novo Services, LLC due to substantial violations in managing controlled substances and maintaining proper recordkeeping. The decision underscores the stringent compliance requirements enforced by federal regulations to protect public health and safety, highlighting the consequences of non-adherence.

Learn More
Notice 18 Apr 2025 regulatory compliance, manufacturing, pharmaceutical industry, controlled substances, drug enforcement

💊Patheon API Services Inc. Applies for Controlled Substances Registration

Patheon API Services Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 compliance, regulation, dea, controlled substances, drug manufacturing, stepan company

⚗️Stepan Company Seeks Registration as Bulk Manufacturer of Controlled Substances

Stepan Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 18 Apr 2025 regulatory compliance, pharmaceuticals, controlled substances, drug enforcement, bulk manufacturing, restek corporation

⚖️Restek Corporation's Bulk Manufacturer Application for Controlled Substances

Restek Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 compliance, united states, pharmaceuticals, manufacturing, controlled substances, drug enforcement, business registration

💊DEA Notice

Research Triangle Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 regulatory compliance, pharmaceuticals, research, dea, controlled substances, scottsdale

💊Notice for Controlled Substances Importer Application by Scottsdale Research Institute

Scottsdale Research Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 18 Apr 2025 compliance, pharmaceuticals, clinical trials, dea, controlled substances, drug enforcement, myonex llc

💊Notice of Application for Controlled Substances by Myonex LLC

Myonex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 16 Apr 2025 regulatory compliance, healthcare, georgia, dea, controlled substances, dentistry

⚖️DEA Suspends Dentist's Registration Over Compliance Violations

The Drug Enforcement Administration has issued an Order to Show Cause and suspended the registration of Lona Bibbs-Walker, D.D.S., citing inadequate records on controlled substances and lack of state authority to practice. The order illustrates critical compliance issues in the healthcare industry, emphasizing the importance of strict adherence to regulatory standards.

Learn More
Notice 16 Apr 2025 compliance, healthcare, regulation, controlled substances, oklahoma, drug enforcement administration, medical licensing

⚖️Revocation of Medical Registration

The Drug Enforcement Administration issued an Order to Show Cause for the revocation of Dr. Henry-Norbert O. Ndekwe's registration due to his lack of authority to handle controlled substances in Oklahoma. The document outlines the legal processes regarding the revocation and highlights the implications for healthcare practitioners and businesses in the industry.

Learn More
Notice 16 Apr 2025 compliance, regulatory, pennsylvania, controlled substances, drug enforcement, pharmacy

💊DEA Revokes Registration of Empire and Skyline Pharmacies for Violations

The Drug Enforcement Administration issued an Order to Show Cause and Immediate Suspension of Registrations to Empire Pharmacy Inc. and Skyline Pharmacy Inc. for alleged violations concerning recordkeeping and dispensing of controlled substances. The order indicates potential revocation of their registration, deeming their operations inconsistent with public safety and legal standards.

Learn More